DK1051158T3 - Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering - Google Patents

Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering

Info

Publication number
DK1051158T3
DK1051158T3 DK99910199T DK99910199T DK1051158T3 DK 1051158 T3 DK1051158 T3 DK 1051158T3 DK 99910199 T DK99910199 T DK 99910199T DK 99910199 T DK99910199 T DK 99910199T DK 1051158 T3 DK1051158 T3 DK 1051158T3
Authority
DK
Denmark
Prior art keywords
extrusion
spheronization
pharmaceutical preparations
polymeric microparticles
microparticles prepared
Prior art date
Application number
DK99910199T
Other languages
Danish (da)
English (en)
Inventor
Fabio Carli
Tiziana Canal
Paolo Gambini
Massimo Bresciani
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Application granted granted Critical
Publication of DK1051158T3 publication Critical patent/DK1051158T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99910199T 1998-02-06 1999-02-05 Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering DK1051158T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000233A IT1298574B1 (it) 1998-02-06 1998-02-06 Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
PCT/EP1999/000781 WO1999039692A2 (en) 1998-02-06 1999-02-05 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization

Publications (1)

Publication Number Publication Date
DK1051158T3 true DK1051158T3 (da) 2002-04-02

Family

ID=11378855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910199T DK1051158T3 (da) 1998-02-06 1999-02-05 Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering

Country Status (15)

Country Link
US (1) US6355273B1 (de)
EP (1) EP1051158B1 (de)
JP (1) JP2002502809A (de)
KR (1) KR20010040727A (de)
AT (1) ATE209905T1 (de)
AU (1) AU738029B2 (de)
BR (1) BR9907682A (de)
CA (1) CA2319463A1 (de)
DE (1) DE69900544T2 (de)
DK (1) DK1051158T3 (de)
ES (1) ES2168855T3 (de)
IT (1) IT1298574B1 (de)
NZ (1) NZ506639A (de)
PT (1) PT1051158E (de)
WO (1) WO1999039692A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
ITRN20000051A1 (it) 2000-12-22 2002-06-22 Ascor Chimici Srl Metodo e apparecchiatura per formare sferule composite contenenti principi attivi del tipo farmaceutico e/o integratori alimentari o cosmeti
DE60223382T2 (de) * 2001-06-29 2008-09-11 Eurand Pharmaceuticals Ltd., Bray Verfahren für die thermodynamische aktivierung von wasserlöslichen arzneimitteln, die in vernetzten polymeren geladen sind
DE60239952D1 (de) * 2001-11-14 2011-06-16 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
EP1446101B1 (de) * 2001-11-14 2011-03-23 Durect Corporation Katheterinjizierbare depotzusammensetzungen und deren verwendung
US6572889B1 (en) * 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003077886A1 (en) * 2002-03-20 2003-09-25 Hosokawa Micron Corporation Method of manufacturing chemical-containing composite particles
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN1684663A (zh) * 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
AU2002359397B2 (en) * 2002-07-31 2009-01-29 Durect Corporation Injectable depot compositions and uses thereof
EP1696888B1 (de) * 2003-12-23 2015-04-08 Temrel Limited Verfahren zur herstellung von pellets für pharmazeutische zusammensetzungen
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
JP5860284B2 (ja) * 2008-12-05 2016-02-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 針状の活性物質を含む押出物
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
ES2882639T3 (es) * 2017-12-28 2021-12-02 Imerys Usa Inc Copolímeros anfifílicos como modificadores de superficie para la producción de polvos de carbonato de calcio mejorados
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
MX9603480A (es) * 1994-02-16 1997-12-31 Abbott Lab Procedimiento para preparar formulaciones farmaceuticas en particulas finas.
DE19504831A1 (de) * 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose

Also Published As

Publication number Publication date
KR20010040727A (ko) 2001-05-15
AU2925199A (en) 1999-08-23
AU738029B2 (en) 2001-09-06
ES2168855T3 (es) 2002-06-16
WO1999039692A3 (en) 1999-09-23
ITMI980233A1 (it) 1999-08-06
NZ506639A (en) 2003-05-30
JP2002502809A (ja) 2002-01-29
PT1051158E (pt) 2002-05-31
CA2319463A1 (en) 1999-08-12
US6355273B1 (en) 2002-03-12
BR9907682A (pt) 2000-11-14
ATE209905T1 (de) 2001-12-15
DE69900544T2 (de) 2002-08-22
DE69900544D1 (de) 2002-01-17
EP1051158A2 (de) 2000-11-15
EP1051158B1 (de) 2001-12-05
IT1298574B1 (it) 2000-01-12
WO1999039692A2 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
DK1051158T3 (da) Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering
DZ2457A1 (fr) Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
FR16C0030I1 (fr) Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
TR199800743A3 (tr) Ispençiyari uygulamaya mahsus devamli salivermeli polimer karisim matrisi.
FR2841900B1 (fr) Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
DZ3000A1 (fr) Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
FR2779438B1 (fr) Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
FI990003A7 (fi) Polymeerikoostumus, menetelmä sen valmistamiseksi ja siitä valmistetut kalvot
FR2796644B1 (fr) Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DZ2702A1 (fr) Nouveaux amides aromatiques leur procédé de préparation et leur application comme médicaments.
NO963462L (no) Paramunitetinducer basert på kombinasjoner av poxvirus komponenter, fremgangsmåte for fremstilling derav og anvendelse som medikament
IT1296464B1 (it) Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
FR2776291B1 (fr) Nouveaux derives bis-benzamides, leur procede de fabrication, les compositions pharmaceutiques les contenant et leur utilisation comme medicament
MA26460A1 (fr) Nouveaux inhibiteurs de farnesyle transferase, leur preparation, les compositions pharmaceutiques qui les contiennent.
DK1345594T3 (da) Fast farmaceutisk sammensætning til kontrolleret frisætning af ivabradin
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
FR2803848B1 (fr) Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2821846B1 (fr) Polymere anti-reflechissant,composition de revetement le contenant et procede de preparation de ce polymere et cette composition
ATE271032T1 (de) Amphiphile polyamin verbindungen
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
FR2772761B1 (fr) Nouveaux derives de n-phenylamide et n-pyridylamide, leur procede de preparation et compositions pharmaceutiques les contenant
MA26606A1 (fr) Derives de 5-desoxycytidine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation.
DZ2976A1 (fr) Inhibiteurs de protéases nouveaux, procédé pour leur préparation et compositions pharmaceutiques lescontenant.